MAML2 and ovarian cancer: We further confirmed that MAML2 knockdown in a YM-fusion-negative ovarian cancer cell line, Heya-8, did not significantly affect cell growth or apoptosis (Figures 5E–5H), further supporting an essential role of the YM fusion in the sustained growth of YM-positive cancer cells.